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The proteasome: a protein-degrading organelle?
The crystal structure of the proteasome suggests that degradation of
ubiquitin-protein conjugates is achieved by unfolding the protein substrate
and translocating it through a channel into a peptidase-containing chamber.
The specificity pockets of intestinal proteases such as
trypsin have long guided thinking about selectivity in
proteolysis. Using the polypeptide ubiquitin to tag pro-
teins for degradation has, by contrast, seemed a rather
baroque approach to the problem of substrate discrimina-
tion. We now know that ubiquitination accounts for the
turnover of cyclins, cyclin-dependent kinase inhibitors,
p53, c-Jun and other oncoproteins [1,2]. However, it has
remained unclear why, of the many known proteolytic
mechanisms, only this one has evolved a tagging step.
Recent studies of the 26S protease, a 2 megadalton com-
plex that degrades ubiquitinated proteins, have pointed
to an elegant explanation [3].
The ability of the 26S protease to degrade proteins gen-
erally depends on both the ubiquitination of the substrate
and the presence of ATP. There are, however, exceptions.
Studies of ornithine decarboxylase showed that these
requirements can be uncoupled: its degradation requires
ATP but not ubiquitin [4]. Moreover, oligopeptide degra-
dation requires neither ubiquitin nor ATP. Based on the
crystal structure of the catalytic core of the 26S protease
[3], these disparate observations can be reconciled by
postulating that ubiquitin and ATP act in different ways
to promote the passage of substrates through the 'mol-
ecular sieve'. At the distal end of the sieve are the pro-
teolytic active sites that degrade the protein. It is the
ability of a protein to pass through the sieve, therefore,
that may qualify it as a substrate.
The catalytic core of the 26S protease is a 20S particle
known as the proteasome (Fig. 1). Although the chem-
istry of degradation occurs in this complex, isolated pro-
teasomes are inactive on physiological substrates and
their activity is not stimulated by either ATP or ubiqui-
tin [5]. The ability of the proteasome to degrade physio-
logical substrates is restored by a complex known as the
19S particle (Fig. 1) [5-8]. A specific subunit of the 19S
particle appears to mediate recognition of ubiquitin-pro-
tein conjugates [9]; this subunit (S5) binds polymers of
ubiquitin even when they have not been linked to any
substrate. Such binding events, which presumably initiate
the degradative process, appear to be ATP-independent,
as is the final event of peptide-bond cleavage. The ATP-
dependence of 26S function may therefore reflect an
intermediate step in the mechanism. As ubiquitin bind-
ing and peptide-bond cleavage occur within different
parts of the 26S protease, the intermediate step may
involve translocation of the substrate from the 19S
particle to the proteasome.
Proteasome active sites
Proteasome subunits are arranged into four heptameric
rings, which are stacked together to form a hollow
cylinder (Fig. 1). In the proteasome from Thermoplasma
acidophilum, an archaebacterium, the subunits are of two
types, at and 3, located in the outer and inner rings,
respectively (Fig. 1) [3]. The eukaryotic forms of these
subunits are surprisingly similar to those of T acidophilum,
although in eukaryotes the a and 13 genes are differenti-
ated into families. In the yeast Saccharomyces cerevisiae, for
example, there are seven at subunit genes and seven 3
subunit genes. The yeast proteasome presumably contains
two copies of each subunit, resulting in a structure with
two-fold (C-2) symmetry [10].
Specific, cell-penetrating inhibitors of the proteasome
have been discovered recently [11,12]. These inhibitors
are active-site-directed agents that covalently bind to 3
subunits of the proteasome, identifying them as the
proteolytically active subunits [3,12]. Remarkably, the co-
valently modified residue in both eukaryotic and archae-
bacterial proteasomes is an amino-terminal threonine
(Thrl) [3,12]; the proteasome therefore exemplifies a new
class of proteases that have threonine as the active-site
nucleophile. In support of this view, substitution of Thrl
with serine in the archaebacterial 13 subunit results in a
fully active protease that has acquired sensitivity to serine
protease inhibitors [13]. Surprisingly, a serine residue has
never been found at position 1 in either archaebacterial or
eukaryotic proteasomes. Perhaps threonine serves more
effectively than serine in amino-terminal propeptide
removal, which has not been assayed using the mutant
proteasomes [13]. Propeptide removal may be essential for
activity because of the extraordinary placement of the
active site at the amino terminus of the mature protein.
The amino group of Thrl might actually participate in
catalysis, substituting for histidine as a general base in the
catalytic triad of serine proteases [3,13].
In the archaebacterial proteasome, all of the 3 subunits are
identical and therefore presumably active. In eukaryotes,
by contrast, three of the seven 3 subunits may be proteo-
lytically active, based on the presence of a Thrl residue
[13]. This is consistent with the existence of at least three
distinct peptidase specificities in the eukaryotic protea-
some, as suggested previously by experiments with chro-
mogenic peptide substrates [5,10,14]. Thus, the protea-
some appears to contain separate active sites for peptides
bearing basic, acidic and hydrophobic residues on the
amino-terminal side of the scissile bond (the P1 position).
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Fig. 1. Structural features of the 26S
protease. Left, contour plot of the 26S
protease derived from electron micro-
scopy and image analysis [24]. Top
right, schematic cross-section of the
proteasome, showing the location of a
subunits (red), subunits (blue) and
peptidase active sites (yellow). Bottom
right, schematic view of subunit
arrangement in the proteasome.
Interestingly, defects in the chymotrypsin-like activity of
the yeast proteasome can result from substitutions in
either of two 3 subunits, Prel or Pre2 [15]. Whereas
Pre2 contains Thrl and is therefore presumably active,
Prel lacks the Thrl residue. These observations,
together with the apparent inactivity of isolated P3 sub-
units, have suggested the existence of cooperative inter-
actions between 3 subunits. By analogy to the structure
of the archaebacterial proteasome, it is now apparent that
the pre2-2 mutation results in the replacement of an
active-site residue. Moreover, the prel-1 mutation can
apparently inhibit Pre2 activity specifically, because the
substituted residue lies within an c helix involved in
V3-3 subunit interactions. Similarly, substitutions in
another two 3 subunits (Pre3 and Pre4) can inhibit the
ability of proteasomes to cleave peptides with acidic P1
residues [10].
In mammals, each of the three active 3 subunits is found
in distinct basal and inducible forms [13,14]. Induction is
mediated by y-interferon-dependent transcriptional reg-
ulation in response to viral infection or other stresses.
That inducible [3 subunits play a role in class I antigen
presentation is well-documented [16-18]. For example,
mice with a targeted deletion of the gene encoding the
inducible LMP-7 subunit present certain antigens ineffi-
ciently. These mice also have reduced cell-surface expres-
sion of MHC class I molecules, which can be restored by
the addition of exogenous peptide [16]. This implies that
LMP-7 is required for peptide supply to MHC class I
molecules. Similar observations are reported for LMP-2
on pages 923-930 of this issue [18]. The presentation of
multiple influenza virus antigens is defective in the
absence of LMP-2 expression [17,18].
One explanation for the phenotype of the LMP-2 and
LMP-7 mutants is that replacing active subunits may
bias the spectrum of oligopeptide degradation products.
As peptides produced by the proteasome seem to serve as
raw material for class I antigen presentation [11,16], an
altered cleavage pattern could enhance the ability of the
immune system to respond to foreign antigens. In this
model, the inducible 'immunoproteasome' generates
peptides with a high affinity for downstream components
of the antigen-presentation pathway, such as the TAP
peptide transporter, which shuttles peptides from the
cytoplasm to the endoplasmic reticulum, or the class I
MHC molecule itself. The influence of inducible [3 sub-
units on the pattern of cleavage sites has yet to be
demonstrated for physiological substrates. However, the
immunoproteasome has an enhanced ability to cleave
chromogenic peptide substrates with hydrophobic
residues at the P1 position [14]. It might therefore prefer-
entially generate degradation products with hydrophobic
carboxyl termini, which are high-affinity substrates for
the TAP transporter [19,20].
Proteasome structure
The crystal structure of the T acidophilum proteasome [3]
shows that its active sites face the central cavity (Fig. 1).
The significance of this observation follows from the
inaccessible nature of the cavity as a whole. The side
walls of the proteasomal cylinder contain no major open-
ings, whereas the faces of the cylinder contain channels
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that are remarkably narrow - no more than 13 A in
diameter (Fig. 1) [3]. In comparison, a helices have
diameters of approximately 11 A. Thus, folded proteins
would not be expected to pass through this channel, as
confirmed in a recent study [21]. Even a 14-residue pep-
tide such as somatostatin cannot be degraded by the pro-
teasome without prior reduction of its disulfide bond.
Moreover, when 20 A nanogold particles are conjugated
to substrate peptides, they accumulate at the orifice of
the proteasome as if they are too large to enter the cavity.
In such complexes, the nanogold-linked peptide cannot
be degraded, nor are free peptides degraded when added
subsequently. This indicates that substrate traffic is
restricted to the orifices at the ends of the cylinder [21].
Another implication of these data is that peptides may
have a significant affinity for the proteasome channel.
The need to sequester major proteases from the cyto-
plasm was suggested decades ago by the discovery of the
lysosome, and subsequent findings that most cytoplasmic
proteins are not degraded in lysosomes only reinforced
the problem. It now appears that the tight shell of the
proteasome substitutes for the phospholipid barrier in
forming a compartmentalized space that is analogous to
the lumen of a cytoplasmic organelle. Another similarity
to protein import into organelles is in the suggested
requirement for proteins to be unfolded before entering
the hydrolytic chamber of the proteasome [21,22].
Unfolding is clearly required for passage through the pro-
tein-conducting channels of the endoplasmic reticulum
and mitochondrion [23]. In the case of the proteasome,
the channel has a hydrophobic character. Each a subunit
contributes a tyrosine residue to form the 13 A sieve;
tyrosines (as well as methionines) are also present within
an internal, 22 A constriction in the cavity of the protea-
some (Fig. 1). The hydrophobicity of these inner surfaces
may stabilize the unfolded forms of substrate proteins as
they migrate toward the active sites [3].
The channels leading into the hydrolytic chamber of the
proteasome open on the outside directly into the 19S
particle (Fig. 1) [24]. Therefore, one may assume that
the 19S particle forms a sister passage which is continu-
ous with the proteasome channel. Remarkably, the 19S
particle contains at least four distinct ATPase subunits
[6-8]. Because interaction of the 19S particle with the
proteasome is ATP-dependent [25], the ATPases possibly
reside at the base of the 19S, contacting the proteasome
directly and lining the substrate's pathway through the
19S particle.
Unfolding
As described above, studies of the proteasome imply that
some factor must act upstream in the pathway to unfold
proteolytic substrates [3,21]. The 19S particle could medi-
ate the unfolding because it directly contacts the protea-
some channel. This model is further supported by the
presence of multiple ATPases in the 19S particle -
ATPases are known to modulate protein folding in other
systems [23]. The 26S ATPases might mediate protein
unfolding by interacting directly with the substrate protein
and having a higher affinity for its unfolded form.
In this hypothetical model, the ATPases bind peptide
segments that are buried in the folded structure of the
protein. Substrate sequences that can interact with the
ATPase would then be expected to be required for
degradation. However, many degradation signals have
been characterized and shown to function by triggering
ubiquitination rather than a later step in the pathway [1].
Perhaps the recognition sites for 26S ATPases are suffi-
ciently degenerate that a typical protein would have
redundant target sites. It is also possible that the ATPases
have different binding specificities, further increasing the
range of substrate sequences that can be bound. These
considerations may help to explain the ability of the 26S
protease to degrade a wide variety of multiubiquitinated
proteins, including proteins that are not normally
degraded but have been engineered to carry a ubiquiti-
nation signal [1]. The ability of the 26S protease to do so
implies that it has a remarkably robust ability to unfold
proteins of different kinds.
Presumably, the ATPases act preferentially on ubiquiti-
nated proteins (see below). According to this view, sub-
strates follow an ordered pathway through the 26S
protease, interacting in a stepwise fashion with a ubiqui-
tin-binding site on subunit S5 [9], an unfolding site that
includes the ATPases, the protein-translocating channel
and finally the peptidase sites of the J3 subunits. This
putative cycle is depicted in Figure 2.
Translocation
The translocation of substrate into the proteasome poses
an interesting set of problems. Which portion of the sub-
strate leads its migration into the proteasome? Is it simply
the structural domain that is most susceptible to unfold-
ing? Another possibility is that the ubiquitination site of
the substrate, being anchored to the 19S particle by the
ubiquitin chain, is prevented from leading translocation.
Can only free ends lead translocation of the substrate, or
is the channel large enough that extended polypeptide
chains can pass through as loops?
The driving force for translocation remains uncertain,
even in many cases of protein translocation across mem-
branes [26]. Recent studies suggest that the unidirection-
ality of protein transport into mitochondria is imparted
by the sequential binding of Hsp70 molecules in the
matrix space [27]. Bound Hsp70 may act as a molecular
ratchet, sterically interfering with retrograde motion. In
the case of the proteasome, it is plausible that the forward
progress of translocation results from hydrolysis of the
substrate at the distal end of the channel. This mechanism
would differ from that of mitochondrial protein import in
that the process driving translocation (peptide-bond
cleavage) does not do so by preventing retrograde motion
of the body of the substrate. However, because the pepti-
dase sites are deep within the cavity of the proteasome,
substantial retrograde motion could occur after a cleavage
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Fig. 2. The putative proteasome cycle.
The proteolytic substrate is shown in
red, ubiquitin in green. The peptidase
sites are shown as blue scissors. For
simplicity, the 26S protease is shown
with a single 19S particle; the 19S parti-
cle is shown without the protein mass
that occupies the mouth of the wedge
(see Fig. 1). Degradation of the substrate
to oligopeptides is accompanied by the
regeneration of free ubiquitin mol-
ecules. Ubiquitin is activated at its car-
boxyl terminus by an El enzyme, then
passed to an E2 enzyme, and finally to
an E3 enzyme (ubiquitin-protein ligase)
[32]. All three enzymes form thiolester
bonds to ubiquitin, although in some
cases the E2 enzyme might directly
donate ubiquitin to target proteins [32].
The proteolytic substrate is linked to
ubiquitin by an isopeptide bond. Multi-
ple ubiquitin groups are added to the
substrate sequentially to form a multi-
ubiquitin chain. The steps of the protea-
some cycle are discussed in the text.
event without aborting translocation. Energetically favor-
able interactions, between the substrate and the
hydrophobic surfaces of the channel and the internal,
22 A constriction, might also serve to minimize abortive
translocation. The same interactions could facilitate initial
'threading' of the channel as well.
Ubiquitin tagging
A major difference between the 26S protease and the
simple, ATP-dependent proteases of Escherichia coli
[28,29], is in the use of a tagging mechanism by the 26S
protease. ATPases of the prokaryotic proteases must
apparently perform both tasks of substrate selection and
substrate unfolding. By holding the substrate in place,
the ubiquitin tag may serve to increase the local concen-
tration of substrate in the vicinity of the 26S ATPases,
and thus to drive the unfolding reaction. In the case of
the chaperone GroE, protein folding is inefficient in that
substrates must undergo multiple cycles of GroE-binding
and ATP-driven release in order to fold [30]. Both pro-
tein unfolding and translocation by the 26S protease
might similarly require multiple trials to reach com-
pletion. However, because the conjugate is anchored by
its ubiquitin tag, the trials might follow one another
without conjugate dissociation from the 26S complex.
Stable binding of the chain during unfolding and translo-
cation motions of the substrate would require flexibility
in the conjugate. For example, the rotational freedom in
the ubiquitin-substrate linkage might allow the substrate
to swivel and thus encounter the ATPases in a range of
orientations. Also, because the chain is a repeating struc-
ture, possible jittering in the register of chain-binding
may allow translational freedom along the pathway of
substrate translocation.
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Upon degradation of substrate, de-ubiquitinating enzymes
regenerate free ubiquitin from the conjugate [1]. This
suggests that ubiquitin is not threaded into the protea-
some along with substrate (Fig. 2). Perhaps this is a result
of the extreme resistance of ubiquitin to unfolding.
Given that ubiquitin cannot enter the proteasome, its
cleavage from the substrate may be necessary for substrate
translocation to be completed. If ubiquitin groups were
attached to multiple lysines within the substrate, they
could prevent translocation altogether. Accordingly, the
multiple ubiquitin groups needed to target proteins for
degradation are generally assembled into a multiubiquitin
chain rather than distributed over the surface of the sub-
strate. Interestingly, the 26S protease has the capacity for
limited proteolysis, which in the case of NF-KB serves to
activate the protein [31]. The undegraded portion of
NF-KB may fail to enter the proteasome channel, either
because of a bound ubiquitin group or because this
domain of NF-KB is inherently resistant to unfolding by
the ATPases.
In summary, the 26S protease, with its signal-recognizing
elements, protein channels and compartmentalized inter-
nal space, has intriguing similarities to organelles. Struc-
tural knowledge of the proteasome has provided a
powerful conceptual framework for future analysis of the
26S protease. The mechanism of this protease is no doubt
far more intricate than we can yet envisage. Despite its
strikingly unique nature, a better understanding of this
particle promises to provide general insights into the
regulation of protein targeting, folding and translocation.
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